Literature DB >> 12241112

Intracranial ganglioglioma: preoperative characteristics and oncologic outcome after surgery.

So-Hyang Im1, Chun Kee Chung, Byung-Kyu Cho, Kyu-Chang Wang, In-Kyu Yu, In Chan Song, Gi Jeong Cheon, Dong Soo Lee, Na-Rae Kim, Je G Chi.   

Abstract

In order to investigate the clinical characteristics, neuroimaging findings, pathological features, treatment, and outcomes, and to provide valuable guidance for the diagnosis and management of intracranial gangliogliomas, 34 cases of intracranial gangliogliomas were retrospectively analyzed. This study included 23 males and 11 females. Age at operation ranged from 17 days to 50 years. All patients had preoperative magnetic resonance imaging (MRI). Computed tomography (CT), magnetic resonance spectroscopy (MRS), 18F-FDG-PET (positron emission tomography), and 99Tc-HMPAO-SPECT (single photon emission computed tomography) were also performed in some cases. All pathological specimens and all available neuroimages were re-evaluated. The follow-up period varied from 12 to 89 months (mean 36 months). Seizure was the most common presenting symptom (85%). Tumor calcification was detected by CT scan in six of 11 cases. Seventeen gangliogliomas (50%) showed cystic components and 18 tumors (53%) were enhanced on MRI. All temporal lobe gangliogliomas were located intracortically and most of them had poor demarcation on MRI. In comparison with the contralateral normal area, the gangliogliomas showed a reduced Cho/Cr and NAA/Cr ratio, and an increased Cho/NAA ratio. On 18F-FDG-PET, gangliogliomas were usually hypometabolic. HMPAO-SPECT indicated tumor hypoperfusion or isoperfusion. A gross total resection was achieved in 25 patients. Tumor progression was observed in three patients who underwent an incomplete tumor resection. Two of them underwent a malignant transformation to a glioblastoma. Twenty-seven patients could carry on their normal life activity with the Karnofsky Performance Scale (KPS) of more than 80. Even though ganglioglioma is a slowly growing benign tumor, which could be demonstrated by magnetic resonance spectroscopy (MRS), PET, and SPECT, there is a chance of malignant transformation, especially in cases of incomplete tumor resection. Gangliogliomas should be resected gross totally, if feasible, to achieve the best long-term outcomes.

Entities:  

Mesh:

Year:  2002        PMID: 12241112     DOI: 10.1023/a:1019661528350

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  14 in total

1.  Ganglioglioma: a clinical study with long-term follow-up.

Authors:  J M Silver; C E Rawlings; E Rossitch; S M Zeidman; A H Friedman
Journal:  Surg Neurol       Date:  1991-04

2.  Malignant transformation in a ganglioglioma with anaplastic neuronal and astrocytic components. Report of a case with flow cytometric and cytogenetic analysis.

Authors:  V Jay; J Squire; L E Becker; R Humphreys
Journal:  Cancer       Date:  1994-06-01       Impact factor: 6.860

Review 3.  MR spectroscopy in clinical research.

Authors:  O Henriksen
Journal:  Acta Radiol       Date:  1994-03       Impact factor: 1.990

4.  Ganglioglioma: a clinical and pathological study of 12 cases.

Authors:  G Isimbaldi; M Sironi; G P Tonnarelli; M Roncoroni; P Declich; C Galli
Journal:  Clin Neuropathol       Date:  1996 Jul-Aug       Impact factor: 1.368

5.  Ganglioglioma in children. A review of 32 cases at the University of Florida.

Authors:  J P Mickle
Journal:  Pediatr Neurosurg       Date:  1992       Impact factor: 1.162

6.  Characterization of intracranial mass lesions with in vivo proton MR spectroscopy.

Authors:  H Poptani; R K Gupta; R Roy; R Pandey; V K Jain; D K Chhabra
Journal:  AJNR Am J Neuroradiol       Date:  1995-09       Impact factor: 3.825

7.  Anaplastic ganglioglioma in an infant: case report and review of the literature.

Authors:  W A Hall; E J Yunis; A L Albright
Journal:  Neurosurgery       Date:  1986-12       Impact factor: 4.654

8.  Ganglioglioma: 13 years of experience.

Authors:  S F Haddad; S A Moore; A H Menezes; J C VanGilder
Journal:  Neurosurgery       Date:  1992-08       Impact factor: 4.654

Review 9.  Anaplastic ganglioglioma: case report and review of the literature.

Authors:  M G Campos; J Zentner; B Ostertun; H K Wolf; J Schramm
Journal:  Neurol Res       Date:  1994-08       Impact factor: 2.448

10.  [18F]2-fluoro-2-deoxyglucose-positron emission tomography correlation of gadolinium-enhanced MR imaging of central nervous system neoplasia.

Authors:  W K Davis; O B Boyko; J M Hoffman; M W Hanson; S C Schold; P C Burger; A H Friedman; R E Coleman
Journal:  AJNR Am J Neuroradiol       Date:  1993 May-Jun       Impact factor: 3.825

View more
  29 in total

1.  Neuro-oncology: gangliogliomas--what is the appropriate management strategy?

Authors:  Minesh P Mehta
Journal:  Nat Rev Neurol       Date:  2010-04       Impact factor: 42.937

2.  Comparisons of MR Findings Between Supratentorial and Infratentorial Gangliogliomas.

Authors:  X Lou; Q-P Gui; L Sun; N-Z Wu; J-H Lyu; L Ma
Journal:  Clin Neuroradiol       Date:  2014-08-23       Impact factor: 3.649

3.  Ganglioglioma in children and young adults: single institution experience and review of the literature.

Authors:  Wafik Zaky; Shekhar S Patil; Minjeong Park; Diane Liu; Wei-Lien Wang; Khalida M Wani; Susana Calle; Leena Ketonen; Soumen Khatua
Journal:  J Neurooncol       Date:  2018-06-07       Impact factor: 4.130

4.  Survivin expression in ganglioglioma.

Authors:  Audrey Rousseau; Michèle Kujas; Anne-Marie Bergemer-Fouquet; Rémy van Effenterre; Jean-Jacques Hauw
Journal:  J Neurooncol       Date:  2005-11-15       Impact factor: 4.130

5.  Susceptibility-weighted imaging: a new tool for detection of intratumoral bleeding and subarachnoid hemorrhage--report of two cases.

Authors:  S S Baldawa; K Bele; G Menon; C V George; M Abraham; S Nair
Journal:  Clin Neuroradiol       Date:  2011-09-09       Impact factor: 3.649

Review 6.  Malignant ganglioglioma: case report and review of literature.

Authors:  Ryan DeMarchi; Suzy Abu-Abed; David Munoz; R Loch Macdonald
Journal:  J Neurooncol       Date:  2010-06-04       Impact factor: 4.130

7.  Brainstem gangliogliomas: prognostic factors, surgical indications and functional outcomes.

Authors:  Chang-Cun Pan; Xin Chen; Cheng Xu; Wen-Hao Wu; Peng Zhang; Yu Wang; Tao Wu; Jie Tang; Xin-Ru Xiao; Zhen Wu; Jun-Ting Zhang; Li-Wei Zhang
Journal:  J Neurooncol       Date:  2016-04-25       Impact factor: 4.130

8.  Epileptogenic brain lesions in children: the added-value of combined diffusion imaging and proton MR spectroscopy to the presurgical differential diagnosis.

Authors:  Slim Fellah; Virginie Callot; Patrick Viout; Sylviane Confort-Gouny; Didier Scavarda; Philippe Dory-Lautrec; Dominique Figarella-Branger; Patrick J Cozzone; Nadine Girard
Journal:  Childs Nerv Syst       Date:  2011-10-27       Impact factor: 1.475

9.  Cerebellar ganglioglioma.

Authors:  Seong-Ho Park; Ealmaan Kim; Eun-Ik Son
Journal:  J Korean Neurosurg Soc       Date:  2008-03-20

Review 10.  [Magnetic resonance spectroscopy of brain tumours].

Authors:  I Harting; G Jost; N Hacke; M Hartmann
Journal:  Nervenarzt       Date:  2005-04       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.